Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

COVID-19 Update:Learn more about how we are protecting our patients, families and staff, as well as other important facts about COVID-19.

Resources for Providers

Providers who would like to refer a patient to be evaluated for our innovative hemimegalencephaly treatment can email us or contact the Neonatal Neurology and Neonatal Neurocritical Care Program at 202-476-2120.

Additional information about our treatment approach:

  • Endovascular embolic hemispherectomy: A strategy for the initial management of catastrophic holohemispheric epilepsy in the neonate
    • Read our published article explaining in detail Children’s National’s experience with two neonates with hemimegalencephaly and intractable seizures. You'll find detailed information about how we managed these patients using a strategy of initial minimally invasive embolization of the cerebral blood supply to the involved hemisphere.
  • Staged transarterial hemispheric embolization: An innovative and effective treatment option for intractable seizures in newborns with hemimegalencephaly (HME)
    • Review our research poster detailing our experience with five newborns with HME and intractable seizures who underwent staged targeted transarterial embolization (TAE).